Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
Clinical trial NCT01773460 · TERMINATED
Trial details
- NCT number
- NCT01773460
- Sponsor
- GBG Forschungs GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-07-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.